Label: LIGHTSAVE TRIPLESOME SERUM TINTED- zinc oxide cream
- NDC Code(s): 83083-020-40
- Packager: Reve Skincare LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated May 25, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredients
- Uses
- Warnings
-
Directions
• apply generously 15 minutes before sun exposure
• reapply: •at least every 2 hours.• use a water resistant sunscreen if swimming or sweating
• Sun Protection Measures. Spending time in the sunincreases your risk of skin cancer and early skin aging. To decrease
this risk, regularly use a sunscreen with a Broad Spectrum SPF
value of 15 or higher and other sun protection measures including:
• limit time in the sun, especially from 10 a.m. - 2 p.m.
• wear long-sleeved shirts, pants, hats, and sunglasses
• children under 6 months of age: Ask a doctor -
Inactive ingredients
Water (Aqua), Caprylic/Capric Triglyceride, Propanediol, Butyloctyl Salicylate, C15-19 Alkane, Sorbitan Oleate Decylglucoside Crosspolymer, Argania Spinosa Kernel Oil, Tocopheryl Acetate, Pentylene Glycol, 1,2-Hexanediol, Panthenol, Sodium Polyacryloyldimethyl Taurate, Lauryl Glucoside, Triethoxycaprylylsilane, Polyglyceryl-6 Laurate, Polyhydroxystearic Acid, Myristyl Glucoside, Propylene Glycol, Sodium Chloride, Camellia Sinensis Leaf Extract, Bisabolol, Dicaprylyl Carbonate, Centella Asiatica Extract, Sodium Citrate, Polyacrylate-13, Xanthan Gum, Ethylhexylglycerin, Citric Acid, Hydrogenated Polyisobutene, Hydroxyacetophenone, Lecithin, Phenethyl Alcohol, Polyglyceryl-10 Laurate, Ethylhexyl Palmitate, Sorbitan Isostearate, Arabidopsis Thaliana Extract, Micrococcus Lysate, Plankton Extract, Tocopherol. May Contain: Iron Oxides (CI 77491, 77492, 77499)
- Other Information
- Questions or Comments?
- Purpose
- Keep out of reach of children.
- Topical
- Principal Display Panel
-
INGREDIENTS AND APPEARANCE
LIGHTSAVE TRIPLESOME SERUM TINTED
zinc oxide creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:83083-020 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 15.7 mg in 1 mL Inactive Ingredients Ingredient Name Strength ETHYLHEXYL PALMITATE (UNII: 2865993309) ARABIDOPSIS THALIANA WHOLE (UNII: AI3L60HQ81) WATER (UNII: 059QF0KO0R) CAPRYLIC/CAPRIC TRIGLYCERIDE (UNII: C9H2L21V7U) BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3) PROPANEDIOL (UNII: 5965N8W85T) C15-19 ALKANE (UNII: CI87N1IM01) ARGANIA SPINOSA KERNEL OIL (UNII: 4V59G5UW9X) 1,2-HEXANEDIOL (UNII: TR046Y3K1G) SORBITAN OLEATE DECYLGLUCOSIDE CROSSPOLYMER (UNII: XF9DUA7ABU) PENTYLENE GLYCOL (UNII: 50C1307PZG) PANTHENOL (UNII: WV9CM0O67Z) SODIUM POLYACRYLOYLDIMETHYL TAURATE (UNII: NG5NG5733T) LAURYL GLUCOSIDE (UNII: 76LN7P7UCU) TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E) POLYGLYCERYL-6 LAURATE (UNII: Q48X4BL3TV) POLYHYDROXYSTEARIC ACID (2300 MW) (UNII: YXH47AOU0F) ISOSTEARIC ACID (UNII: X33R8U0062) POLYGLYCERYL-3 PENTARICINOLEATE (UNII: 7Q0OK5DOT4) MYRISTYL GLUCOSIDE (UNII: 6AK28695LF) SODIUM CHLORIDE (UNII: 451W47IQ8X) XANTHAN GUM (UNII: TTV12P4NEE) CAMELLIA SINENSIS LEAF (UNII: W2ZU1RY8B0) BISABOLOL (UNII: 24WE03BX2T) DICAPRYLYL CARBONATE (UNII: 609A3V1SUA) CENTELLA ASIATICA WHOLE (UNII: 7M867G6T1U) SODIUM CITRATE (UNII: 1Q73Q2JULR) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) CITRIC ACID (UNII: 2968PHW8QP) HYDROGENATED POLYBUTENE (1300 MW) (UNII: 7D1YQ9Y5EZ) HYDROXYACETOPHENONE (UNII: G1L3HT4CMH) LECITHIN, SOYBEAN (UNII: 1DI56QDM62) PHENETHYL ALCOHOL (UNII: ML9LGA7468) POLYGLYCERYL-10 LAURATE (UNII: MPJ2Q8WI8G) BROWN IRON OXIDE (UNII: 1N032N7MFO) SORBITAN ISOSTEARATE (UNII: 01S2G2C1E4) TOCOPHEROL (UNII: R0ZB2556P8) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:83083-020-40 1 in 1 CARTON 06/09/2025 1 40 mL in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M020 06/09/2025 Labeler - Reve Skincare LLC (118831764)